TAK stock sets October 29 results date ahead of the Xetra open
Published on 10/19/2026 at 07:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly results date confirmed
- Takeda scheduled its fiscal second-quarter results release for October 29, 2026.
- Takeda develops medicines in gastroenterology, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.
- TAK stock trades pre-market at EUR 17.60 at 7:28 a.m. CEST at Lang & Schwarz on October 19, 2026.
Takeda Pharmaceutical Company Limited said on October 15, 2026, that it plans to publish fiscal second-quarter results on October 29, 2026, according to Takeda Pharmaceutical. The stock trades pre-market at EUR 17.60 at 7:28 a.m. CEST at Lang & Schwarz on October 19, 2026.
Results date on the calendar
Takeda said the fiscal second-quarter results will be released at 3:30 p.m. Japan time on October 29, 2026. The company also plans an online earnings presentation and question-and-answer session from 7:00 p.m. to 8:15 p.m. Japan time that day, with materials scheduled for publication on its website at the results release time, according to Takeda Pharmaceutical.
A diversified pharmaceutical business
Takeda develops and provides medicines in gastroenterology, inflammatory diseases, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines, according to Takeda Pharmaceutical. Market context: Market report Nikkei 225. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Takeda Pharmaceutical stock.
